期刊
CURRENT ISSUES IN MOLECULAR BIOLOGY
卷 44, 期 5, 页码 2186-2193出版社
MDPI
DOI: 10.3390/cimb44050148
关键词
RNA sequencing; formalin-fixed paraffin-embedded samples; library preparation
资金
- national program Cartes d'Identite des Tumeurs (CIT) - Ligue Nationale Contre le Cancer
RNA sequencing (RNA-Seq) is a powerful tool with significant clinical potential, especially in oncology. This study compared five FFPE-compatible kits for RNA-Seq and found that the Smarter Pico V3 ribodepletion approach was the most reliable and reproducible technique, with comparable performance to Nanostring and Truseq. In addition, the 3' Lexogen kit showed an interesting quality-price ratio for samples with limited quantities.
RNA sequencing (RNA-Seq) appears as a great tool with huge clinical potential, particularly in oncology. However, sufficient sample size is often a limiting factor and the vast majority of samples from patients with cancer are formalin-fixed paraffin-embedded (FFPE). To date, several sequencing kits are proposed for FFPE samples yet no comparison on low quantities were performed. To select the most reliable, cost-effective, and relevant RNA-Seq approach, we applied five FFPE-compatible kits (based on 3 ' capture, exome-capture and ribodepletion approaches) using 8 ng to 400 ng of FFPE-derived RNA and compared them to Nanostring on FFPE samples and to a reference PolyA (Truseq) approach on flash-frozen samples of the same tumors. We compared gene expression correlations and reproducibility. The Smarter Pico V3 ribodepletion approach appeared systematically the most comparable to Nanostring and Truseq (p < 0.001) and was a highly reproducible technique. In comparison with exome-capture and 3 ' kits, the Smarter appeared more comparable to Truseq (p < 0.001). Overall, our results suggest that the Smarter is the most robust RNA-Seq technique to study small FFPE samples and 3 ' Lexogen presents an interesting quality-price ratio for samples with less limiting quantities.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据